Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Response to Letter]

Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Response to Letter]

Michael Z Liao,1 Johannes Kast,1 Marloes Berkhout,2 Hans Prenen,3 Sandeep Dutta,4 Vijay V Upreti1 1Clinical Pharmacology, Modeling & Simulation, Amgen Inc., South San Francisco, CA, USA; 2Amgen B.V., Breda, the Netherlands; 3Antwerp University Hospital, Edegem, Belgium; 4Clinical Pharmacolog...

Full description

Bibliographic Details
Main Authors: Liao MZ, Kast J, Berkhout M, Prenen H, Dutta S, Upreti VV
Format: Article
Language:English
Published: Dove Medical Press 2020-12-01
Series:Clinical Pharmacology: Advances and Applications
Subjects:
panitumumab
pharmacokinetics
dose-exposure relationship
body weight
area under the curve
colorectal neoplasms
Online Access:https://www.dovepress.com/response-is-bodyweight-based-dosing-truly-better-than-flat-dosing-for--peer-reviewed-article-CPAA

Internet

https://www.dovepress.com/response-is-bodyweight-based-dosing-truly-better-than-flat-dosing-for--peer-reviewed-article-CPAA

Similar Items